State of New Jersey Common Pension Fund D Boosts Stock Holdings in Oscar Health, Inc. (NYSE:OSCR)

State of New Jersey Common Pension Fund D grew its position in Oscar Health, Inc. (NYSE:OSCR) by 6.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 116,555 shares of the company’s stock after purchasing an additional 6,965 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Oscar Health were worth $1,566,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the company. Rhumbline Advisers grew its position in shares of Oscar Health by 2.4% during the 4th quarter. Rhumbline Advisers now owns 271,227 shares of the company’s stock valued at $3,645,000 after purchasing an additional 6,483 shares in the last quarter. Vontobel Holding Ltd. bought a new position in Oscar Health during the 4th quarter worth approximately $370,000. SMART Wealth LLC bought a new stake in Oscar Health during the 4th quarter valued at $180,000. Tempus Wealth Planning LLC bought a new position in shares of Oscar Health during the fourth quarter valued at about $181,000. Finally, GDS Wealth Management lifted its holdings in Oscar Health by 1,545.3% in the 4th quarter. GDS Wealth Management now owns 345,817 shares of the company’s stock worth $4,648,000 after buying an additional 324,798 shares during the period. 75.70% of the stock is owned by institutional investors.

Insider Transactions at Oscar Health

In related news, CFO Richard Scott Blackley sold 25,279 shares of the company’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $457,044.32. Following the sale, the chief financial officer now directly owns 881,841 shares in the company, valued at approximately $15,943,685.28. This represents a 2.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Steven Wolin sold 19,580 shares of the firm’s stock in a transaction that occurred on Monday, December 2nd. The shares were sold at an average price of $18.08, for a total transaction of $354,006.40. Following the completion of the sale, the chief operating officer now directly owns 102,598 shares in the company, valued at approximately $1,854,971.84. This trade represents a 16.03 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 78,610 shares of company stock valued at $1,421,269. 25.11% of the stock is currently owned by company insiders.

Oscar Health Price Performance

NYSE:OSCR opened at $15.65 on Wednesday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26. Oscar Health, Inc. has a 52 week low of $12.43 and a 52 week high of $23.79. The stock’s 50-day moving average price is $14.89 and its 200-day moving average price is $16.64. The stock has a market capitalization of $3.87 billion, a PE ratio of -782.01 and a beta of 1.73.

Oscar Health (NYSE:OSCR) last announced its earnings results on Tuesday, February 4th. The company reported ($0.62) EPS for the quarter, missing analysts’ consensus estimates of ($0.55) by ($0.07). Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. As a group, equities analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current fiscal year.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Bank of America lowered shares of Oscar Health from a “neutral” rating to an “underperform” rating and decreased their price target for the stock from $21.00 to $13.50 in a research note on Wednesday, November 6th. Jefferies Financial Group initiated coverage on shares of Oscar Health in a report on Tuesday, December 10th. They issued an “underperform” rating and a $12.00 price objective for the company. Two research analysts have rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $21.56.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.